Expression and clinical significance of BRCA1 in familial thyroid carcinoma
10.3760/cma.j.issn.1674-6090.2017.06.017
- VernacularTitle:乳腺癌易感基因1在家族性甲状腺癌中的表达及临床意义
- Author:
Min ZHANG
1
;
Yongqiang YAO
;
Hong FANG
;
Jiping XIE
;
Yi WAN
;
Ziwei ZHAO
Author Information
1. 116000,大连大学附属中山医院乳腺甲状腺外科
- Keywords:
BRCA1;
Thyroid carcinoma;
Familial
- From:
Chinese Journal of Endocrine Surgery
2017;11(6):513-516
- CountryChina
- Language:Chinese
-
Abstract:
Objective To investigate the expression of BRCA1 in familial thyroid cancer (FTC) and the relationship between BRCA1 expression and clinicopathologic features.Methods The expression of BRCA1 protein and mRNA was detected respectively by immunohistochemistry and RT-PCR in 37 FTC tissues,35 sporadic thyroid carcinoma tissues and 35 normal thyroid tissues.Results BRCA1 mRNA expression was significantly downregulated in FTC (0.210±0.025) compared with sporadic thyroid carcinoma(0.943±0.021) and normal thyroid tissues(1.001±0.087)(P＜0.01).The positive rate of BRCA1 protein expression was significantly lower in FTC(56.8％,21/37) than that in sporadic thyroid carcinoma(85.7％,30/35) and normal thyroid tissues(94.5％,33/35) (P＜0.05).There was a correlation between BRCA1 protein expression and FTC clinicopathologic features (P＜0.05).FTC patients with lower BRCA1 protein expression tended to have higher risk for bilateral carcinoma,lymph node metastasis,capsular invasion,morbidity under 30 years old and more than 2 patients in a family.Conclusions The expression of BRCA1 protein and mRNA is downregnlated in FTC.BRCA1 protein might serve as a potential biomarker for predicating biological behavior and prognosis of FTC.
